Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shoulder implant under review: will it last 10 years?

NCT ID NCT05002959

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at a shoulder implant used to treat pain and joint problems from conditions like arthritis, fractures, and rotator cuff tears. It involved 67 adults who received the implant and tracked how long it lasted and any side effects over 10 years. The goal was to confirm the implant is safe and works well.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

67 people

The number who actually took part.

Started

Feb 2022

Finished

Mar 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Subjects who have received a T.E.S.S.® Version 3 Anatomic or Reverse shoulder prosthesis from January 2013, based on the Indications for Use and who meet all of the inclusion and none of exclusion criteria.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient is 18 years or older and skeletally mature * Patient is capable of understanding the surgeon's explanations and following his instructions, able and willing to participate in the follow-up program * Patient gave consent to take part in the study by signing the Informed Consent Form * Patient operated from January 2013 and received the Anatomic or Reverse T.E.S.S.® V3 Modular Total Shoulder System to relieve pain and restore the joint function * Patient has adequate quality and quantity of bone stock to support the prosthesis * Patient meets at least one of the following indications: For anatomic type: * Centered osteoarthritis of the shoulder * Humeral head fractures * Rheumatoid arthritis (with intact rotator cuff) * Avascular necrosis of the humeral head * Revision of a hemi-arthroplasty with a total arthroplasty * Revision of a reverse prosthesis with an anatomic prosthesis * Revision to increase the size of the stem (length and/or diameter) * Revision of a glenoid prosthesis, a glenoid insert or a competitor's prosthesis For reverse type: * Offset osteoarthritis of the shoulder * Massive and non-repairable rotator cuff tears * Rheumatoid arthritis (with degenerative rotator cuff) * Revision of an anatomic prosthesis with a reverse prosthesis * Revision to increase the size of the stem (length and/or diameter) * Revision of a glenoid prosthesis, a glenoid insert or a competitor's prosthesis Exclusion Criteria: * Patient is unwilling or unable to give consent or to comply with the follow-up program * Patient is known to be pregnant or breastfeeding * Patient has any condition that would, in the judgment of the Investigator, place the patient at undue risk or interfere with the study * Patient is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, anticipated to be non-compliant) * Patient who displays any of the following contra-indications cannot be included in this study: * Local or systemic infections * Severe muscular, neurological, or vascular deficiency of the affected joint * Poor bone quality likely to prevent osseointegration or to affect the long-term stability of the implant (Paget's disease, osteoporosis) * Any concomitant conditions likely to affect the function of the implant * Allergy to any of the implant components * Do not use the modular humeral version (screwed connection) in cases where the corolla cannot be two-thirds covered with bone stock and including the screwed modular stem/corolla junction

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Avascular necrosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

avascular necrosis Fractures, Malunited humerus fracture osteoarthritis osteonecrosis rheumatoid arthritis Rotator Cuff Injuries rotator cuff syndrome Rotator Cuff Tear Arthropathy Shoulder Fractures

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinique Saint-Jean (Group ORTHOSUD)

    Saint-Jean-de-Védas, France

  • Lyon Ortho Clinic

    Lyon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.